In order to promote the standardized diagnosis and treatment of esophageal cancer, promote the standardization and standardization process of esophageal cancer diagnosis and treatment in China, and gradually realize standardization, specialization, standardization, refinement and informatization, and ultimately benefit the majority of patients, Chengdu High-tech Medical Association successfully held the 2022 China CSCO Esophageal Cancer Diagnosis and Treatment Guidelines Western Region Tour online on September 3, 2022.

Due to the needs of epidemic prevention and control, this meeting was held online. Experts from the meeting covered experts from Sichuan Cancer Hospital, the First Affiliated Hospital of Chongqing Medical University, Cancer Hospital of Chinese Academy of Medical Sciences, Stomatological Hospital of Air Force Military Medical University, and West China Hospital of Sichuan University. All the participating experts carried out an inspiring collision of ideas in the form of academic conferences and case sharing.

The conference invited well-known experts in the field of esophageal cancer from all provinces in China to give lectures, focusing on topics such as adverse reactions caused by esophageal cancer immunotherapy and chemotherapy, and building a platform for exchange and learning for experts and colleagues in the form of academic lectures and case discussions. It provides a platform for the exchange of diagnosis and treatment technology and academic scientific research results for the majority of clinical medical practitioners and scientific research workers.